227 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Amar
    Amar
  4. Norton
    Norton
  5. Kris
    Kris
  6. Morris
    Morris
  7. Mulhall
    Mulhall
  8. Papanicolaou
    Papanicolaou
  9. Tap
    Tap
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)
  7. Population Sciences Research Program (20)
  8. Epidemiology and Biostatistics (18)
  9. Hematologic Malignancies, Division of (18)
  10. Breast Medicine Service (17)
  1. "double blind procedure"
Formats
  1. Journal Article (219)
  2. Conference Paper (3)
  3. Correspondence (3)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)

More Groups

People
  1. Howard Scher (10)
  2. Robert Motzer (10)
  3. David Amar (7)
  4. Jose Baselga (7)
  5. Larry Norton (7)
  6. Genovefa Papanicolaou (6)

More People

Years
  1. 2025 (4)
  2. 2024 (21)
  3. 2023 (13)
  4. 2022 (12)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Lancet Oncology (20)
  3. New England Journal of Medicine (17)
  4. Clinical Cancer Research (9)
  5. Lancet (8)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Science, Inc. (37)
  2. Elsevier Inc. (28)
  3. American Society of Clinical Oncology (21)
  4. Oxford University Press (19)
  5. Lippincott Williams & Wilkins (17)
  6. Massachusetts Medical Society (17)

More Publishers

Results (227)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
    Journal Article

    Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. M.; Morris, M.; Kantoff, P.; Monk, J. P.; Kaplan, E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Journal Article

    Aghajanian, C.; Blank, S. V.; Goff, B. A.; Judson, P. L.; Teneriello, M. G.; Husain, A.; Sovak, M. A.; Yi, J.; Nycum, L. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: A randomized, double-blind phase III trial
    Journal Article

    Wells, S. A. Jr; Robinson, B. G.; Gagel, R. F.; Dralle, H.; Fagin, J. A.; Santoro, M.; Baudin, E.; Elisei, R.; Jarzab, B.; Vasselli, J. R.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Prostate cancer risk in men with prostate and breast cancer family history: Results from the REDUCE study (R1)
    Journal Article

    Thomas, J. A.; Gerber, L.; Moreira, D. M.; Hamilton, R. J.; Bañez, L. L.; Castro-Santamaria, R.; Andriole, G. L.; Isaacs, W. B.; Xu, J.; Freedland, S. J.
    Journal of Internal Medicine (2012)

    Fulltext@MSK | Save
  • Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma
    Journal Article

    Kindler, H. L.; Karrison, T. G.; Gandara, D. R.; Lu, C.; Krug, L. M.; Stevenson, J. P.; Jänne, P. A.; Quinn, D. I.; Koczywas, M. N.; Brahmer, J. R.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial
    Journal Article

    Miller, V. A.; Hirsh, V.; Cadranel, J.; Chen, Y. M.; Park, K.; Kim, S. W.; Zhou, C.; Su, W. C.; Wang, M.; Sun, Y.; more...
    Lancet Oncology (2012)

    Fulltext@MSK | Save
  • Hormonal contraception and the risk of HIV acquisition among women in South Africa
    Journal Article

    Morrison, C. S.; Skoler Karpoff, S.; Kwok, C.; Chen, P. L.; Van De Wijgert, J.; Gehret-Plagianos, M.; Patel, S.; Ahmed, K.; Ramjee, G.; Friedland, B.; more...
    AIDS (2012)

    Fulltext@MSK | Save
  • The APC and PreSAP trials: A post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo
    Journal Article

    Arber, N.; Lieberman, D.; Wang, T. C.; Zhang, R.; Sands, G. H.; Bertagnolli, M. M.; Hawk, E. T.; Eagle, C.; Coindreau, J.; Zauber, A.; more...
    Clinical Therapeutics (2012)

    Fulltext@MSK | Save
  • Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the Cancer and Leukemia Group B (CALGB 80303)
    Journal Article

    Romanus, D.; Kindler, H. L.; Archer, L.; Basch, E.; Niedzwiecki, D.; Weeks, J.; Schrag, D.
    Journal of Pain and Symptom Management (2012)

    Fulltext@MSK | Save
  • Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: A Children's Oncology Group study
    Journal Article

    Gilman, A. L.; Schultz, K. R.; Goldman, F. D.; Sale, G. E.; Krailo, M. D.; Chen, Z.; Langholz, B.; Jacobsohn, D. A.; Chan, K. W.; Ryan, R. E.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save